Clinical Trials Sponsored by Korean Multiple Myeloma Working Party

Total 7 results

Korean Multiple Myeloma Working Party
Celgene Corporation

Unknown

PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Korea, Republic of
Korean Multiple Myeloma Working Party
Celgene Corporation

Unknown

TCD Followed by autoSCT for Newly Diagnosed MM Patients

Multiple Myeloma

Korea, Republic of
Korean Multiple Myeloma Working Party
Janssen-Cilag Ltd.

Completed

VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates

Multiple Myeloma

Korea, Republic of
Korean Multiple Myeloma Working Party
Janssen-Cilag Ltd.

Unknown

Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

Multiple Myeloma

Korea, Republic of
Seoul National University Hospital
Korean Society of Hematology Thrombosis Working Party

Completed

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Recurrence | Bleeding | Cancer-associated Thrombosis | Rivaroxaban

Korea, Republic of
Ulsan University Hospital
The Korean Society of Hematology CML working party

Unknown

Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML (NICE-BORA)

Untreated Adult Acute Myeloid Leukemia | Chronic Myeloid Leukemia in Myeloid Blast Crisis

Korea, Republic of
Ulsan University Hospital
The Korean Society of Hematology, AML/MDS Working Party

Unknown

Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice (PURPLE-D)

Acute Myeloid Leukemia | Elderly | Intensive Chemotherapy Unfit

Korea, Republic of

Clinical Trials Sponsored by Korean Multiple Myeloma Working Party

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations